Key facts
- It has raised $2.0M; the latest was Seed Round ($2.0M) in Sep 2025.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Luminari
- ·The full record, as it builds
Funding rounds
No funding rounds for Luminari are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Luminari
Developer of a blockchain-based platform intended to streamline clinical trial processes. The company's platform leverages AI to provide a digital twin patient simulation, identify gaps, forecast desired outcomes, and make real-time adjustments and predict and identify participants with the highest probability of achieving desired outcomes, helping healthcare professionals simplify patient recruitment, make informed decisions, reduce protocol development timelines, and increase efficiency.
- Sector
- Healthcare
- HQ
- Wheeling, IL, United States
- Founded
- 2024
- Website
- luminaricro.com/
- Ownership
- Privately Held (backing)
Luminari doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Luminari shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Luminari in its N-PORT filings yet. We sweep new filings monthly.